Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

Literature DB >> 30442736

Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

Therese B Bevers, Mark Helvie, Ermelinda Bonaccio, Kristine E Calhoun, Mary B Daly, William B Farrar, Judy E Garber, Richard Gray, Caprice C Greenberg, Rachel Greenup, Nora M Hansen, Randall E Harris, Alexandra S Heerdt, Teresa Helsten, Linda Hodgkiss, Tamarya L Hoyt, John G Huff, Lisa Jacobs, Constance Dobbins Lehman, Barbara Monsees, Bethany L Niell, Catherine C Parker, Mark Pearlman, Liane Philpotts, Laura B Shepardson, Mary Lou Smith, Matthew Stein, Lusine Tumyan, Cheryl Williams, Mary Anne Bergman, Rashmi Kumar.

Abstract

The NCCN Guidelines for Breast Cancer Screening and Diagnosis have been developed to facilitate clinical decision making. This manuscript discusses the diagnostic evaluation of individuals with suspected breast cancer due to either abnormal imaging and/or physical findings. For breast cancer screening recommendations, please see the full guidelines on NCCN.org.

Entities: Disease

Mesh：

Year: 2018 PMID： 30442736 DOI： 10.6004/jnccn.2018.0083

Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908

Keyword Cloud
Cited

87 in total

1. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.

Authors: Jennifer M Yeh; Kathryn P Lowry; Clyde B Schechter; Lisa R Diller; Oguzhan Alagoz; Gregory T Armstrong; John M Hampton; Wendy Leisenring; Qi Liu; Jeanne S Mandelblatt; Diana L Miglioretti; Chaya S Moskowitz; Kevin C Oeffinger; Amy Trentham-Dietz; Natasha K Stout
Journal: Ann Intern Med Date: 2020-07-07 Impact factor: 25.391

2. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.

Authors: Aniruddh P Patel; Minxian Wang; Akl C Fahed; Heather Mason-Suares; Deanna Brockman; Renee Pelletier; Sami Amr; Kalotina Machini; Megan Hawley; Leora Witkowski; Christopher Koch; Anthony Philippakis; Christopher A Cassa; Patrick T Ellinor; Sekar Kathiresan; Kenney Ng; Matthew Lebo; Amit V Khera
Journal: JAMA Netw Open Date: 2020-04-01

3. Breast cancer early detection and diagnostic capacity in Uganda.

Authors: John R Scheel; Mahbod J Giglou; Sophie Segel; Jackson Orem; Vivien Tsu; Moses Galukande; Jimmy Okello; Gertrude Nakigudde; Noleb Mugisha; Zeridah Muyinda; Benjamin O Anderson; Catherine Duggan
Journal: Cancer Date: 2020-05-15 Impact factor: 6.860

Review 4. Interventions to improve adherence to surveillance guidelines in survivors of childhood cancer: a systematic review.

Authors: Veda Zabih; Alyssa Kahane; Natalya E O'Neill; Noah Ivers; Paul C Nathan
Journal: J Cancer Surviv Date: 2019-07-24 Impact factor: 4.442

5. HER2 assessment by bright-field dual in situ hybridization in cell blocks of recurrent and metastatic breast carcinoma.

Authors: Marcia Edelweiss; Ana Paula Martins Sebastiao; Handy Oen; Mihaela Kracun; Rene Serrette; Dara S Ross
Journal: Cancer Cytopathol Date: 2019-09-22 Impact factor: 5.284

10. Correlation of HER2 codon 655 polymorphism with cardiotoxicity risk in Chinese HER2-positive breast cancer patients undergoing epirubicin/cyclophosphamide followed by docetaxel plus trastuzumab adjuvant chemotherapy.

Authors: Lun Tan; Xinyu Su; Xun Li; Hai Li; Bo Hu
Journal: Int J Clin Exp Pathol Date: 2020-02-01

Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

1. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.

2. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.

3. Breast cancer early detection and diagnostic capacity in Uganda.

Review 4. Interventions to improve adherence to surveillance guidelines in survivors of childhood cancer: a systematic review.

5. HER2 assessment by bright-field dual in situ hybridization in cell blocks of recurrent and metastatic breast carcinoma.

6. YouTube as a source of information on breast cancer in the Arab world.

7. Complex Solid and Cystic Breast Cancer: A Series of Six Case Reports.

Review 8. Counselling framework for moderate-penetrance cancer-susceptibility mutations.

Review 9. Breast density implications and supplemental screening.

10. Correlation of HER2 codon 655 polymorphism with cardiotoxicity risk in Chinese HER2-positive breast cancer patients undergoing epirubicin/cyclophosphamide followed by docetaxel plus trastuzumab adjuvant chemotherapy.